חוב כולל של החברה: Trinity Biotech PLC (TRIB)

The stability of Trinity Biotech plc (TRIB) is confirmed by sales of CGM monitors and HIV tests, as evidenced by the changes in debt load displayed on GURU.Markets; 0.00 serves as the current parameter value. The business relies on global supplies of reagents for diabetes diagnostics. Resilience is ensured by the installed instrument base and asset optimization, which protects the company's current margins.

This metric is critical when stress-testing business resilience to credit risks and assessing the issuer's solvency. The total volume of borrowed funds, reflected through total liabilities, measures the aggregate debt load, where the downward debt trend for Trinity Biotech plc (TRIB) signifies the release of resources for expansion into the wearable biosensors segment while maintaining a narrow specialization in laboratory diagnostics.